Mixed options sentiment in Eli Lilly (LLY), with shares up $11.64, or 1.67%, near $709.70. Options volume roughly in line with average with 57k contracts traded and calls leading puts for a put/call ratio of 0.42, compared to a typical level near 0.68. Implied volatility (IV30) dropped 0.93 near 29.09,in the bottom quartile of the past year, suggesting an expected daily move of $13.00. Put-call skew steepened, indicating increased demand for downside protection.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LLY:
- Viking Therapeutics drop may be partially ‘sell the news,’ says H.C. Wainwright
- Eli Lilly & Co’s Orforglipron Faces Hold Rating Amid Concerns Over GI Side Effects in Clinical Trials
- Positive Market Outlook for Eli Lilly’s Orforglipron Following ATTAIN-1 Trial Results
- Eli Lilly, Novo Nordisk up 2% each after Viking obesity pill trial results
- Analysts Rally Behind Eli Lilly (LLY) Stock After 24% Slide